Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services

$OTLCPress releaseJun 17, 2026, 8:00 AM ETRead the release

Oncotelic completed Phase 2 objectives in its joint initiative with TechForce Robotics to advance an AI-powered GMP manufacturing platform at its SAPU Bio joint venture. The deployment expands the proprietary PDAOAI platform across sterile manufacturing operations, including electronic batch records and autonomous materials movement.

Key figures

Sapu bio ownership percentage: 45%

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.